Screener
Baxter International BAX Pharmaceuticals — Segment operating income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Baxter International’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028962
| (in millions) | Three Months Ended March 31, 2026 / Medical Products & Therapies | Three Months Ended March 31, 2026 / Healthcare Systems & Technologies | Three Months Ended March 31, 2026 / Pharmaceuticals | Three Months Ended March 31, 2025 / Medical Products & Therapies | Three Months Ended March 31, 2025 / Healthcare Systems & Technologies | Three Months Ended March 31, 2025 / Pharmaceuticals |
|---|---|---|---|---|---|---|
| Net sales | $1,285 | $705 | $621 | $1,262 | $704 | $581 |
| Cost of sales | 781 | 390 | 458 | 694 | 356 | 396 |
| Selling, general and administrative expenses | 290 | 209 | 102 | 286 | 217 | 103 |
| Research and development expenses | 54 | 49 | 22 | 59 | 45 | 26 |
| Other segment items | (26) | (9) | (7) | (21) | (7) | (7) |
| Segment operating income | $186 | $66 | $46 | $244 | $93 | $63 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Baxter International's pharmaceuticals — segment operating income?
- Baxter International (BAX) reported pharmaceuticals — segment operating income of $46M in Q1 2026.
- How has Baxter International's pharmaceuticals — segment operating income changed year-over-year?
- Baxter International's pharmaceuticals — segment operating income decreased by 27.0% year-over-year, from $63M to $46M.
- What is the long-term trend for Baxter International's pharmaceuticals — segment operating income?
- Over 3 years (2021 to 2025), Baxter International's pharmaceuticals — segment operating income has grown at a -24.8% compound annual growth rate (CAGR), from $523M to $222M.
- What does pharmaceuticals — segment operating income mean?
- Measures the profitability of the Pharmaceuticals segment by subtracting cost of sales, operating expenses, and R&D from net sales. It provides a clear view of the segment's core operational performance before interest and taxes.
Ask your AI about Baxter International's pharmaceuticals — segment operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude